Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease

Céline Morissette, Diane Lacombe, Xianqi Kong, Ahmed Aman, Pascale Krzywkowski, Lioudmila Rodionova, Mounia Azzi, Daniel Delorme, Barry D. Greenberg

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Amyloid refers to extracellular proteinaceous fibrillar tissue deposits having a unique set of morphologic, tinctorial, ultrastructural, and protein-folding characteristics (Kisilevsky, 1996). Up to now, more than 25 amyloid proteins or peptides have been identified, each being associated with one type of amyloid deposit (for a review see: Westermark et al., 2005).

Original languageEnglish (US)
Title of host publicationPharmacological Mechanisms in Alzheimer's Therapeutics
PublisherSpringer New York
Pages255-273
Number of pages19
ISBN (Electronic)9780387715223
ISBN (Print)9780387715216
DOIs
StatePublished - 2007
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this